Thermo Fisher Scientific Inc. TMO
Set alert
697.00 USD -12.18 -1.72%
At close · Oct 30
696.18 -0.82 -0.12%
After hours · Oct 30, 7:00 PM ET
691.74 Day range 711.79
438.34 52-week range 709.18
- YTD
- +20.29%
- 1 year
- +25.31%
- Open
- 710.69
- Prev close
- 709.18
- Mkt cap
- 257.71B
- Vol
- 2.09M
- Avg vol
- 2.09M
- EPS
- 18.96
- P/E
- 36.76
- Div yield
- 0.27%
More statistics
- Low
- 691.74
- High
- 711.79
- Forward P/E
- 25.11
- Beta
- 0.88
- Short ratio
- 1.98
- Inst. own
- 93.55%
- Dividend
- 1.88
- Ex-div date
- Sep 14, 2026
- Earnings
- Feb 4, 2027
- 50-d avg
- 653.26
- 200-d avg
- 550.99
- 1y target
- 752.12
MAX chart
Events in this range
- Jun 6, 1996Split: 3 for 2
- Oct 30, 2026Rating: Argus Research · Buy → Buy
Signals (48)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 2026 | 2 days ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Jun 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| SMA: Bearish | Sep 1, 2023 | 3 years ago |
| SMA: Bullish | Jun 1, 2023 | 3 years ago |
| SMA: Bearish | Mar 1, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 1, 2023 | 3 years ago |
| RSI: Overbought | Dec 1, 2016 | 9 years ago |
| RSI: Overbought | Mar 1, 2016 | 10 years ago |
| RSI: Overbought | Jun 1, 2013 | 13 years ago |
| MACD: Buy Signal | Sep 1, 2012 | 14 years ago |
| SMA: Bullish | Jun 1, 2012 | 14 years ago |
| SMA: Bearish | Mar 1, 2012 | 14 years ago |
| SMA: Bullish | Dec 1, 2011 | 14 years ago |
| SMA: Bearish | Sep 1, 2011 | 15 years ago |
| MACD: Sell Signal | Sep 1, 2011 | 15 years ago |
| MACD: Buy Signal | Mar 1, 2011 | 15 years ago |
| SMA: Bullish | Sep 1, 2010 | 16 years ago |
| SMA: Bearish | Jun 1, 2010 | 16 years ago |
| SMA: Bullish | Dec 1, 2009 | 16 years ago |
| MACD: Sell Signal | Dec 1, 2008 | 17 years ago |
| SMA: Bearish | Sep 1, 2008 | 18 years ago |
| RSI: Overbought | Sep 1, 2006 | 20 years ago |
| SMA: Bullish | Dec 1, 2003 | 22 years ago |
| MACD: Buy Signal | Sep 1, 2003 | 23 years ago |
| SMA: Bullish | Jun 1, 2003 | 23 years ago |
| SMA: Bearish | Dec 1, 2001 | 24 years ago |
| SMA: Bearish | Jun 1, 2001 | 25 years ago |
| MACD: Sell Signal | Jun 1, 2001 | 25 years ago |
| MACD: Buy Signal | Mar 1, 2001 | 25 years ago |
| SMA: Bullish | Sep 1, 2000 | 26 years ago |
| SMA: Bullish | Jun 1, 2000 | 26 years ago |
| SMA: Bearish | Jun 1, 1998 | 28 years ago |
| SMA: Bearish | Mar 1, 1998 | 28 years ago |
| MACD: Sell Signal | Mar 1, 1998 | 28 years ago |
| RSI: Overbought | Dec 1, 1997 | 28 years ago |
| RSI: Overbought | Jun 1, 1997 | 29 years ago |
| RSI: Overbought | Jun 1, 1994 | 32 years ago |
| RSI: Overbought | Dec 1, 1992 | 33 years ago |
| SMA: Bullish | Sep 1, 1990 | 36 years ago |
| SMA: Bearish | Jun 1, 1990 | 36 years ago |
| SMA: Bullish | Dec 1, 1988 | 37 years ago |
| SMA: Bearish | Sep 1, 1987 | 39 years ago |
Financial health
Altman Z-Score
4.18 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 3
- Return on Equity 4
- Return on Assets 4
- Debt / Equity 1
- P/E 2
- P/B 2
Valuation
P/E 32.6×
FY 2016 5y median 32.6× FY 2025
P/S 4.9×
FY 2016 5y median 4.8× FY 2025
P/B 4.1×
FY 2016 5y median 4.4× FY 2025
P/FCF 34.6×
FY 2016 5y median 31.2× FY 2025
EV/EBITDA 21.6×
FY 2016 5y median 20.8× FY 2025
EV/Sales 5.6×
FY 2016 5y median 5.4× FY 2025
FCF Yield 2.9%
FY 2016 5y median 3.2% FY 2025
Profitability
Gross Margin 40.9%
FY 2016 5y median 41.3% FY 2025
Operating Margin 18.2%
FY 2016 5y median 18.2% FY 2025
Net Margin 15.1%
FY 2016 5y median 15.1% FY 2025
ROE 12.6%
FY 2016 5y median 12.8% FY 2025
ROIC 7.6%
FY 2016 5y median 8.0% FY 2025
ROA 6.1%
FY 2016 5y median 6.5% FY 2025
Growth (YoY)
Revenue 3.9%
FY 2016 FY 2025
Operating Income 5.8%
FY 2016 FY 2025
EPS (diluted) 7.3%
FY 2016 FY 2025
Free Cash Flow -13.4%
FY 2016 FY 2025
Financial Health
Current Ratio 1.9×
FY 2016 5y median 1.7× FY 2025
Quick Ratio 1.5×
FY 2016 5y median 1.3× FY 2025
Debt / Equity 0.7×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 2.6×
FY 2016 5y median 2.5× FY 2025
Interest Coverage 5.7×
FY 2016 5y median 5.7× FY 2025
Dividends
Dividend Yield 0.3%
FY 2016 5y median 0.3% FY 2025
Payout Ratio 9.4%
FY 2016 5y median 8.7% FY 2025
Annual · latest fiscal year ends 2025-12-31